<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>K-Ras is frequently mutated in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Mutant (mt) K-Ras can stimulate both oncogenic transformation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> through activation of extracellular signal-regulated kinase (ERK) and AKT pathways and the MST2 pathway, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>The biological outcome is determined by the balance and cross talk between these pathways </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), a K-Ras mutation is negatively correlated with MST2 expression, as mt K-Ras can induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by activating the MST2 pathway </plain></SENT>
<SENT sid="4" pm="."><plain>However, <z:mp ids='MP_0002169'>wild-type</z:mp> (wt) K-Ras can prevent the activation of the MST2 pathway upon growth factor stimulation and enable transformation by mt K-Ras in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells that express MST2 </plain></SENT>
<SENT sid="5" pm="."><plain>Here we have investigated the mechanism by which wt and mt K-Ras differentially regulate the MST2 pathway and MST2-dependent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>The ability of K-Ras to activate MST2 and MST2-dependent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is determined by the differential activation kinetics of mt K-Ras and wt K-Ras </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> activation of K-Ras by mutation or overexpression of Ras exchange factors results in the activation of MST2 and LATS1, increased MST2-LATS1 complex formation, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, transient K-Ras activation upon epidermal growth factor (EGF) stimulation prevents the formation of the MST2-LATS1 complex in an AKT-dependent manner </plain></SENT>
<SENT sid="9" pm="."><plain>Our data suggest that the close relationship between Ras prosurvival and proapoptotic signaling is coordinated via the differential regulation of the MST2-LATS1 interaction by transient and <z:hpo ids='HP_0011010'>chronic</z:hpo> stimuli </plain></SENT>
</text></document>